From Oncology to Building for Pharma at YC | Ankr Health CEO Arpit Rao
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
From Oncology to Building for Pharma at YC | Ankr Health CEO Arpit Rao
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
In this episode of The Healthcare Theory, we’re joined by Dr. Arpit Rao, oncologist and co-founder of Ankr Health, a Y Combinator-backed startup using AI to transform cancer care.
We explore his path from running FDA clinical trials to launching a platform that predicts treatment-limiting side effects before they happen. He also discusses the startup’s go-to-market journey, including their first major deal with AstraZeneca, and how they’ve built a solution tailored specifically for the pharma industry. This conversation is a powerful look into how machine learning can improve outcomes, reduce patient drop-off, and reimagine the future of oncology care.
Ce que les auditeurs disent de From Oncology to Building for Pharma at YC | Ankr Health CEO Arpit Rao
Moyenne des évaluations de clientsÉvaluations – Cliquez sur les onglets pour changer la source des évaluations.
Il n'y a pas encore de critiques pour ce titre.